Today's Rundown Featured Story | | | Thursday, January 10, 2019 Denali Therapeutics is teaming up with Sirion Biotech to expand into gene therapies. The partners will work to develop adeno-associated virus vectors capable of crossing the blood-brain barrier. |
|
|
Top Stories Thursday, January 10, 2019 A cancer vaccine being developed by Epitopoietic Research Corp. has become the first drug to be given to a U.S. patient under new "right-to-try" legislation that gives terminally ill patients access to experimental drugs. Thursday, January 10, 2019 The FDA shutdown is holding up human trials for Aimmune's egg allergy program and may delay approval for its oral immunotherapy for peanut allergy. Monday, January 7, 2019 Biopharmaceutical science has the capability to drive change in our society and write a new storyline for public health. However, science alone will not achieve this change. So what can? Thursday, January 10, 2019 Versant Ventures’ Black Diamond Therapeutics has raised $85 million. The series B, which comes weeks after Black Diamond exited stealth mode, tees the allosteric oncogenic mutation specialist up to move two or three candidates into the clinic. Wednesday, January 9, 2019 Schrödinger has snared $85 million in financing that will be used to support its computational platform and expand its pipeline. Resources Presented by: Aprecia Get ahead of looming challenges in the market that include both generic products and new branded drugs. Sponsored by: Oracle Health Sciences New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM). Sponsored by: Veeva Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar. Sponsored by: DocuSign Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin? Sponsored by: Veeva Learn how to spot an imposter with an integrated suite vs. one that’s unified. Read this whitepaper to learn more. Sponsored by: Outer Edge Technology Outer Edge Technology specializes in designing and managing regulated cloud-based infrastructures for the Life Sciences Industry – typically leveraging the AWS and Microsoft Azure platforms. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
